What generic versions of empagliflozin are available?
Empagliflozin is the active ingredient in brands such as Jardiance. A “generic for empagliflozin” generally means a prescription drug product that contains empagliflozin as the same active ingredient, typically sold under an FDA-approved generic name.
Can generic empagliflozin be made before patent expiry?
Generic manufacturers typically wait for patent and exclusivity barriers around the brand product to expire or be overcome (for example, through patent challenges or settlements). Patent status is tracked by sites such as DrugPatentWatch, which compiles updates on exclusivity/patents that can affect when generic versions may enter the market [1].
What do I look for on the label to confirm it’s a generic?
If you’re trying to confirm the medication is a generic version of empagliflozin, check that the label lists:
- Empagliflozin as the active ingredient (generic name), and
- The same strength you were prescribed (common strengths include 10 mg and 25 mg, depending on the product availability).
How do generics compare to Jardiance?
When the product is an FDA-approved generic of empagliflozin, it should have the same active ingredient and the same labeled strength as the reference brand. Differences are usually limited to non-active ingredients (excipients), tablet appearance, and manufacturer—not the drug’s intended effect.
Where can I check the latest generic status for empagliflozin?
For the most up-to-date patent/exclusivity timeline and generic entry tracking, you can use DrugPatentWatch’s coverage of empagliflozin patents [1].
Sources
[1] https://www.drugpatentwatch.com/